Patents by Inventor Ida Rosenkrands

Ida Rosenkrands has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecular differences between species of the M. tuberculosis complex
    Publication number: 20040018574
    Abstract: Specific genetic deletion are identified in mycobacteria isolates, including variations in the M. tuberculosis genome sequence between isolates, and numerous deletion present in BCG as compared to M. tbThe genetic markers can be used for diagnosis of M. tb. infection. One or more antigens provided from the genetic markers can be used in diagnostic assays, e.g. a serological assay.
    Type: Application
    Filed: March 14, 2003
    Publication date: January 29, 2004
    Inventors: Marcel Behr, Peter Small, Michael A. Wilson, Gary Schoolnik, Claus Aagaard, Ida Rosenkrands, Karin Weldingh, Peter Andersen
  • Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
    Patent number: 6641814
    Abstract: The present invention is based on the identification and characterization of a number of M. tuberculosis derived novel proteins and protein fragments (SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 17-23, 42, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72-86, 88, 90, 92, 94, 141, 143, 145, 147, 149, 151, 153, and 168-171). The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as vaccines and skin test reagents containing the polypeptides. Another part of the invention is based on the surprising discovery that fusions between ESAT-6 and MPT59 are superior immunogens compared to each of the unfused proteins, respectively.
    Type: Grant
    Filed: March 30, 1998
    Date of Patent: November 4, 2003
    Assignee: Statens Serum Institut
    Inventors: Peter Andersen, Rikke Nielsen, Thomas Oettinger, Peter Birk Rasmussen, Ida Rosenkrands, Karin Weldingh, Walter Florio
  • Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
    Publication number: 20020094336
    Abstract: The present invention is based on the identification and characterization of a number of M. tuberculosis derived novel proteins and protein fragments (SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 17-23, 42, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72-86, 88, 90, 92, 94, 141, 143, 145, 147, 149, 151, 153, and 168-171). The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as vaccines and skin test reagents containing the polypeptides. Another part of the invention is based on the surprising discovery that fusions between ESAT-6 and MPT59 are superior immunogens compared to each of the unfused proteins, respectively.
    Type: Application
    Filed: February 20, 2001
    Publication date: July 18, 2002
    Applicant: STATENS SERUM INSTITUT
    Inventors: Peter Andersen, Rikke Nielsen, Thomas Oettinger, Peter Birk Rasmussen, Ida Rosenkrands, Karin Weldingh, Walter Florio